NCT04003402View on ClinicalTrials.gov

A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

ASP8062

oral

DRUG

Alcohol

oral

DRUG

ASP8062 Placebo

oral

DRUG

Alcohol Placebo

oral

Trial Locations (1)

21225

Parexel International - EPCU Baltimore, Baltimore

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT04003402 - A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter